Imatinib Tablets IP – 400 mg

Imatinib 400 mg is a prescription medication used to treat certain types of cancer, including:

• Chronic myeloid leukemia (CML) in adults and children
• Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in adults and children
• Myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR gene re-arrangements in adults
• Advanced hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) with FIP1L1-PDGFRα rearrangement in adults
• Kit (CD117)-positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST) in adults
• Adjuvant treatment of adults with Kit (CD117)-positive GIST at significant risk of relapse following resection
• Unresectable dermatofibrosarcoma protuberans (DFSP) in adults